Birchview Capital’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Hold
30,000
1.13% 27
2025
Q4
$1.91M Hold
30,000
1.12% 25
2025
Q3
$1.65M Buy
30,000
+20,000
+200% +$824K 1.24% 23
2025
Q2
$330K Hold
10,000
0.33% 50
2025
Q1
$402K Hold
10,000
0.35% 37
2024
Q4
$470K Hold
10,000
0.38% 35
2024
Q3
$528K Hold
10,000
0.46% 29
2024
Q2
$542K Hold
10,000
0.5% 30
2024
Q1
$701K Sell
10,000
-15,000
-60% -$1.16M 0.57% 30
2023
Q4
$2.09M Hold
25,000
1.63% 12
2023
Q3
$737K Hold
25,000
0.63% 27
2023
Q2
$816K Hold
25,000
0.61% 29
2023
Q1
$880K Hold
25,000
0.69% 22
2022
Q4
$1.15M Hold
25,000
0.81% 19
2022
Q3
$1.21M Hold
25,000
0.85% 23
2022
Q2
$982K Hold
25,000
0.71% 22
2022
Q1
$920K Hold
25,000
0.66% 28
2021
Q4
$1.14M Hold
25,000
0.74% 27
2021
Q3
$894K Buy
25,000
+15,000
+150% +$442K 0.61% 30
2021
Q2
$198K Buy
+10,000
New +$235K 0.12% 59
2019
Q4
Sell
-10,000
Closed -$114K 53
2019
Q3
$114K Hold
10,000
0.08% 43
2019
Q2
$113K Hold
10,000
0.07% 49
2019
Q1
$81K Hold
10,000
0.05% 51
2018
Q4
$63K Hold
10,000
0.06% 50
2018
Q3
$99K Hold
10,000
0.06% 51
2018
Q2
$83K Hold
10,000
0.06% 52
2018
Q1
$72K Hold
10,000
0.05% 48
2017
Q4
$82K Hold
10,000
0.05% 40
2017
Q3
$145K Buy
+10,000
New +$137K 0.07% 37

Other funds holding CYTK